|
Name |
2-(2-Hydroxy-5-methoxyphenyl)-4-methoxyphenol
|
| Molecular Formula | C14H14O4 | |
| IUPAC Name* |
2-(2-hydroxy-5-methoxyphenyl)-4-methoxyphenol
|
|
| SMILES |
COC1=CC(=C(C=C1)O)C2=C(C=CC(=C2)OC)O
|
|
| InChI |
InChI=1S/C14H14O4/c1-17-9-3-5-13(15)11(7-9)12-8-10(18-2)4-6-14(12)16/h3-8,15-16H,1-2H3
|
|
| InChIKey |
ZOTPRNGZOCVFQN-UHFFFAOYSA-N
|
|
| Synonyms |
2,2'-Bi(4-methoxyphenol); SCHEMBL8440252; 5,5'-dimethoxybiphenyl-2,2'-diol; 5,5'-dimethoxy-2,2'-dihydroxybiphenyl; 5,5'-dimethoxy[1,1'-biphenyl]-2,2'-diol; 2-(2-hydroxy-5-methoxyphenyl)-4-methoxyphenol; 2,2'-dihydroxy-5,5'-dimethyoxy-1,1'-biphenyl; 2,2'-Dihydroxyl-5,5'-dimethoxy-1,1'-biphenyl
|
|
| CAS | NA | |
| PubChem CID | 10014791 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 246.26 | ALogp: | 2.8 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 58.9 | Aromatic Rings: | 2 |
| Heavy Atoms: | 18 | QED Weighted: | 0.869 |
| Caco-2 Permeability: | -4.695 | MDCK Permeability: | 0.00001750 |
| Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.011 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.022 |
| 30% Bioavailability (F30%): | 0.192 |
| Blood-Brain-Barrier Penetration (BBB): | 0.113 | Plasma Protein Binding (PPB): | 98.86% |
| Volume Distribution (VD): | 0.576 | Fu: | 1.72% |
| CYP1A2-inhibitor: | 0.961 | CYP1A2-substrate: | 0.954 |
| CYP2C19-inhibitor: | 0.841 | CYP2C19-substrate: | 0.177 |
| CYP2C9-inhibitor: | 0.567 | CYP2C9-substrate: | 0.953 |
| CYP2D6-inhibitor: | 0.894 | CYP2D6-substrate: | 0.945 |
| CYP3A4-inhibitor: | 0.752 | CYP3A4-substrate: | 0.329 |
| Clearance (CL): | 11.832 | Half-life (T1/2): | 0.641 |
| hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.076 |
| Drug-inuced Liver Injury (DILI): | 0.717 | AMES Toxicity: | 0.569 |
| Rat Oral Acute Toxicity: | 0.095 | Maximum Recommended Daily Dose: | 0.214 |
| Skin Sensitization: | 0.856 | Carcinogencity: | 0.12 |
| Eye Corrosion: | 0.383 | Eye Irritation: | 0.976 |
| Respiratory Toxicity: | 0.606 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004820 | ![]() |
0.429 | D0DJ1B | ![]() |
0.366 | ||
| ENC002205 | ![]() |
0.402 | D05CKR | ![]() |
0.342 | ||
| ENC002759 | ![]() |
0.395 | D0U3YB | ![]() |
0.341 | ||
| ENC005040 | ![]() |
0.393 | D04KJO | ![]() |
0.333 | ||
| ENC003034 | ![]() |
0.391 | D0D1DI | ![]() |
0.333 | ||
| ENC005039 | ![]() |
0.386 | D0Q1IT | ![]() |
0.333 | ||
| ENC002952 | ![]() |
0.385 | D09WKB | ![]() |
0.333 | ||
| ENC005870 | ![]() |
0.382 | D09GYT | ![]() |
0.324 | ||
| ENC005871 | ![]() |
0.382 | D08LFZ | ![]() |
0.320 | ||
| ENC006073 | ![]() |
0.380 | D00KRE | ![]() |
0.310 | ||